TABLE 2

Number and percentage of chronic comorbidities (as elaborated in the supplementary material) at the time of sleep apnoea diagnosis for all those diagnosed with sleep apnoea in Finland in 2017

Men (n=16‚ÄČ263)Women (n=9061)
Cases (n)Prevalence (%)Cases (n)Prevalence (%)p-value
Cancer8715.365365.920.070
Kidney and urinary tract disease5553.412322.56<0.001
Thyroid disease3372.078919.83<0.001
Other metabolic disease5633.465526.09<0.001
Diabetes332420.44170518.820.006
Obesity10536.47105311.62<0.001
Gastro-oesophageal reflux disease3111.913353.70<0.001
Dementia and other cerebral disorders7034.322913.21<0.001
Schizophrenia and delusional disorders2151.321411.560.133
Mood and neurotic disorders16069.88174619.27<0.001
Nonorganic sleep disorders3552.183353.70<0.001
Neurological disorders12217.51123213.60<0.001
Glaucoma2341.441932.13<0.001
Hypertension421725.93275230.37<0.001
Cardiovascular disease375723.10220224.300.059
Atrial fibrillation14969.206347.00<0.001
Other respiratory disease165310.16131114.47<0.001
Gastrointestinal disease267116.42206522.79<0.001
Musculoskeletal disease579735.65471752.06<0.001
Urogenital disease14408.852062.27<0.001
Heart failure6243.843193.52<0.001
Cerebrovascular disease5323.272963.270.211
Organic sleep disorders1971.211751.930.985
Asthma9675.94113712.55<0.001
COPD5723.522933.230.744
Dyslipidaemia174510.7398510.870.242